Your browser doesn't support javascript.
Lactate Dehydrogenase to Albumin ratio as a Predictive Factor of COVID-19 Patients' Outcome; a Cross-sectional Study.
Alizadeh, Nafiseh; Tabatabaei, Fatemeh-Sadat; Azimi, Amirali; Faraji, Neda; Akbarpour, Samaneh; Dianatkhah, Mehrnoush; Moghaddas, Azadeh.
  • Alizadeh N; Department of Pharmaceutical Care, Baharlou Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Tabatabaei FS; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Azimi A; Men's Health and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Faraji N; Department of Internal Medicine, Baharlou Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Akbarpour S; Occupational Sleep Research Center, Baharlou Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Dianatkhah M; Department of Clinical Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Moghaddas A; Department of Clinical Pharmacy and Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, Cancer Prevention Research Center, Seyyed Al-Shohada Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.
Arch Acad Emerg Med ; 10(1): e63, 2022.
Article in English | MEDLINE | ID: covidwho-1998132
ABSTRACT

Introduction:

 Despite the increasing vaccination coverage, COVID-19 is still a concern. With the limited health care capacity, early risk stratification is crucial to identify patients who should be prioritized for optimal management. The present study investigates whether on-admission lactate dehydrogenase to albumin ratio (LAR) can be used to predict COVID-19 outcomes.

Methods:

This retrospective cross-sectional study evaluated hospitalized COVID-19 patients in an academic referral center in Iran from May 2020 to October 2020. The area under the receiver operating characteristic (ROC) curve (AUC) was used to evaluate the value of LAR in the prediction of mortality. The Yuden index was used to find the optimal cut-off of LAR to distinguish severity. Patients were classified into three groups (LAR tertiles), first LAR<101.46, second 101.46≤LAR< 148.78, and third group LAR≥148.78. Logistic regression analysis was used to identify the association between tertiles of LAR, as well as the relationship between each one-unit increase in LAR with mortality and ICU admission in three models, based on potential confounding variables.

Results:

A total of 477 patients were included. Among all patients, 100 patients (21%) died, and 121 patients (25.4%) were admitted to intensive care unit (ICU). In the third group, the risk of mortality and ICU admission increased 7.78 times (OR=7.78, CI 3.95-15.26; p <0.0001) and 4.49 times (OR=4.49, CI 2.01-9.04; p <0.0001), respectively, compared to the first group. The AUC of LAR for prediction of mortality was 0.768 (95% CI 0.69- 0.81). LAR ≥ 136, with the sensitivity and specificity of 72% (95%CI 62.1-80.5) and 70% (95%CI 64.9-74.4), respectively, was the optimal cut-off value for predicting mortality.

Conclusion:

High LAR was associated with higher odds of COVID-19 mortality, ICU admission, and length of hospitalization. On-admission LAR levels might help health care workers identify critical patients early on.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Language: English Journal: Arch Acad Emerg Med Year: 2022 Document Type: Article Affiliation country: Aaem.v10i1.1646

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Language: English Journal: Arch Acad Emerg Med Year: 2022 Document Type: Article Affiliation country: Aaem.v10i1.1646